Regeneron Pharmaceuticals | REGN - درآمد حاصل از بهره

قیمت سهام
751.57
تغییر روزانه
-14.45 -1.89%
ماهیانه
0.28%
سالیانه
24.71%
Q2 پیش بینی
735.49




درآمد حاصل از بهره تغییر دادن تاریخ
AbbVie USD 72M 10M 2025-09
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Astellas Pharma JPY 4.12B 2.94B 2024-03
AstraZeneca USD 85M 17M 2025-09
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 26M 24M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.14 237M 2026-03
Kyowa Hakko Kirin JPY 2.54B 1.52B 2024-06
Merck USD 96M 27M 2025-09
Moderna USD 73M 8M 2025-09
Pfizer USD 0.62 156M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09